![](/img/cover-not-exists.png)
245 Remission/low disease activity is an achievable treatment target in psoriatic arthritis (PsA): results from a routine care European cohort of PsA patients treated with ustekinumab or TNF inhibitors
Siebert, Stefan, Gossec, Laure, Bergmans, Paul, de Vlam, Kurt, Gremese, Elisa, Joven, Beatriz E, Korotaeva, Tatiana, Wright, Pamela B, Kent, Toby, Noel, Wim, Nurmohamed, Michael, Sfikakis, Petros, SmiVolume:
58
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kez107.061
Date:
April, 2019
File:
PDF, 63 KB
english, 2019